Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322742016> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4322742016 endingPage "4" @default.
- W4322742016 startingPage "1" @default.
- W4322742016 abstract "Aims: In this study, we aim to discover if there is a difference between COVID 19 antibody level in hematological patients taking conventional chemotherapy and tyrosin kinase inhibitors. Methods: COVİD 19 IgG levels were measured using the QuantiCOR anti-SARS-CoV-2 IgG ELISA test kit on 74 patients who received chemotherapy and used tyrosine kinase inhibitors in the adult hematology clinic of Turgut Özal Medical Center between May 2019 and January 2022. Age, height, weight, badimeks index of the patients were measured, the doses and durations of vaccine use, the time between the first vaccine and the second vaccine, how long after the first vaccine antibodies were checked, and vaccine-related side effects were recorded. Collected data Statistical analysis was performed using Python 3.9 and IBM SPSS Statistics for Windows version 26.0 (New York; USA). Results: Antibody levels of the patients were significantly higher in the healthy control group than in the groups that received chemotherapy and tyrosine kinase inhibitors. Antibody levels of female patients in the control group were higher than male patients. Antibody levels of the patient groups receiving chemotherapy and tyrosine kinase inhibitor were not found to differ between the two groups. When the patients receiving B lymphocyte suppressing chemotherapy in the chemotherapy group were compared with the control group, antibody levels were found to be higher in the control group. Conclusion: COVID 19 vaccination in hematological cancers did not produce adequate antibody response, especially in patients receiving chemotherapy or tyrosine kinase inhibitors." @default.
- W4322742016 created "2023-03-03" @default.
- W4322742016 creator A5011481838 @default.
- W4322742016 creator A5012448800 @default.
- W4322742016 creator A5016162173 @default.
- W4322742016 creator A5022059136 @default.
- W4322742016 creator A5043661730 @default.
- W4322742016 creator A5046745413 @default.
- W4322742016 creator A5059747985 @default.
- W4322742016 creator A5064556397 @default.
- W4322742016 creator A5066464955 @default.
- W4322742016 creator A5077108549 @default.
- W4322742016 creator A5087200352 @default.
- W4322742016 date "2023-02-26" @default.
- W4322742016 modified "2023-10-17" @default.
- W4322742016 title "Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID 19 antibody level in hematological patients" @default.
- W4322742016 doi "https://doi.org/10.51271/jchor-0001" @default.
- W4322742016 hasPublicationYear "2023" @default.
- W4322742016 type Work @default.
- W4322742016 citedByCount "0" @default.
- W4322742016 crossrefType "journal-article" @default.
- W4322742016 hasAuthorship W4322742016A5011481838 @default.
- W4322742016 hasAuthorship W4322742016A5012448800 @default.
- W4322742016 hasAuthorship W4322742016A5016162173 @default.
- W4322742016 hasAuthorship W4322742016A5022059136 @default.
- W4322742016 hasAuthorship W4322742016A5043661730 @default.
- W4322742016 hasAuthorship W4322742016A5046745413 @default.
- W4322742016 hasAuthorship W4322742016A5059747985 @default.
- W4322742016 hasAuthorship W4322742016A5064556397 @default.
- W4322742016 hasAuthorship W4322742016A5066464955 @default.
- W4322742016 hasAuthorship W4322742016A5077108549 @default.
- W4322742016 hasAuthorship W4322742016A5087200352 @default.
- W4322742016 hasBestOaLocation W43227420161 @default.
- W4322742016 hasConcept C121608353 @default.
- W4322742016 hasConcept C126322002 @default.
- W4322742016 hasConcept C159654299 @default.
- W4322742016 hasConcept C170493617 @default.
- W4322742016 hasConcept C194409129 @default.
- W4322742016 hasConcept C203014093 @default.
- W4322742016 hasConcept C22070199 @default.
- W4322742016 hasConcept C2776694085 @default.
- W4322742016 hasConcept C2778820342 @default.
- W4322742016 hasConcept C42362537 @default.
- W4322742016 hasConcept C71924100 @default.
- W4322742016 hasConcept C90924648 @default.
- W4322742016 hasConceptScore W4322742016C121608353 @default.
- W4322742016 hasConceptScore W4322742016C126322002 @default.
- W4322742016 hasConceptScore W4322742016C159654299 @default.
- W4322742016 hasConceptScore W4322742016C170493617 @default.
- W4322742016 hasConceptScore W4322742016C194409129 @default.
- W4322742016 hasConceptScore W4322742016C203014093 @default.
- W4322742016 hasConceptScore W4322742016C22070199 @default.
- W4322742016 hasConceptScore W4322742016C2776694085 @default.
- W4322742016 hasConceptScore W4322742016C2778820342 @default.
- W4322742016 hasConceptScore W4322742016C42362537 @default.
- W4322742016 hasConceptScore W4322742016C71924100 @default.
- W4322742016 hasConceptScore W4322742016C90924648 @default.
- W4322742016 hasIssue "1" @default.
- W4322742016 hasLocation W43227420161 @default.
- W4322742016 hasOpenAccess W4322742016 @default.
- W4322742016 hasPrimaryLocation W43227420161 @default.
- W4322742016 hasRelatedWork W2033795993 @default.
- W4322742016 hasRelatedWork W2045818256 @default.
- W4322742016 hasRelatedWork W2170131546 @default.
- W4322742016 hasRelatedWork W2557669062 @default.
- W4322742016 hasRelatedWork W2600451726 @default.
- W4322742016 hasRelatedWork W3031877964 @default.
- W4322742016 hasRelatedWork W3032613505 @default.
- W4322742016 hasRelatedWork W4229980099 @default.
- W4322742016 hasRelatedWork W4233417786 @default.
- W4322742016 hasRelatedWork W4384120537 @default.
- W4322742016 hasVolume "1" @default.
- W4322742016 isParatext "false" @default.
- W4322742016 isRetracted "false" @default.
- W4322742016 workType "article" @default.